Paying users zone. Data is covered by hidden.

  • Get 1 month access to Regeneron Pharmaceuticals Inc. for $13.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Regeneron Pharmaceuticals Inc. (REGN)


Common-Size Income Statement

Difficulty: Beginner

Regeneron Pharmaceuticals Inc., Common-Size Consolidated Income Statement

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net product sales hidden hidden hidden hidden hidden
Sanofi collaboration revenue hidden hidden hidden hidden hidden
Bayer collaboration revenue hidden hidden hidden hidden hidden
Other revenue hidden hidden hidden hidden hidden
Revenues hidden hidden hidden hidden hidden
Cost of goods sold hidden hidden hidden hidden hidden
Cost of collaboration and contract manufacturing hidden hidden hidden hidden hidden
Cost of revenues hidden hidden hidden hidden hidden
Gross profit hidden hidden hidden hidden hidden
Research and development hidden hidden hidden hidden hidden
Selling, general, and administrative hidden hidden hidden hidden hidden
Income from operations hidden hidden hidden hidden hidden
Other income (expense), net hidden hidden hidden hidden hidden
Interest expense hidden hidden hidden hidden hidden
Other income (expense) hidden hidden hidden hidden hidden
Income before income taxes hidden hidden hidden hidden hidden
Income tax expense hidden hidden hidden hidden hidden
Net income hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

Item Description The company
Income from operations The net result for the period of deducting operating expenses from operating revenues. Regeneron Pharmaceuticals Inc.’s income from operations as a percentage of revenues increased from 2016 to 2017 and from 2017 to 2018.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Regeneron Pharmaceuticals Inc.’s income before income taxes as a percentage of revenues increased from 2016 to 2017 and from 2017 to 2018.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Regeneron Pharmaceuticals Inc.’s net income as a percentage of revenues increased from 2016 to 2017 and from 2017 to 2018.